Abstract
The following article from Clinical and Translational Medicine, "CD248 as a novel therapeutic target in pulmonary arterial hypertension" by Tao Xu, Lei Shao, Aimei Wang, Rui Liang, Yuhan Lin, GuanWang, Yan Zhao, Jing Hu, and Shuangyue Liu,1 published online on September 17, 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Xiangdong Wang and John Wiley & Sons, Ltd. The retraction has been agreed due to duplicate use of figures and data in the article. REFERENCE 1 Xu T, Shao L, Wang A, Liang R, Lin Y, Wang G, Zhao Y, Hu J, Liu S. CD248 as a novel therapeutic target in pulmonary arterial hypertension. Clin Transl Med. 2020;10:e175.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
